(396 days)
No
The document describes a standard contact lens with UV blocking properties and does not mention any AI or ML components in its intended use, device description, or performance studies.
No.
The device is indicated for the correction of refractive ametropia and UV protection, which are not considered therapeutic treatments.
No
The device is a contact lens used for the correction of refractive ametropia (myopia and hyperopia), not for diagnosing conditions.
No
The device description clearly states it is a physical contact lens made of a silicon combination hydrogel material, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. They are used outside the body.
- Device Function: The VISCO Soft Contact Lens is a device that is placed on the eye to correct vision. It does not perform any tests on bodily samples.
- Intended Use: The intended use is for the correction of refractive errors (myopia and hyperopia) and astigmatism, and to protect against UV radiation. These are therapeutic and protective functions, not diagnostic ones.
- Device Description: The description details the physical properties and materials of the contact lens, not components or processes related to in vitro testing.
Therefore, the VISCO Soft Contact Lens falls under the category of a medical device, but specifically a therapeutic or corrective device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The VISCO Soft (Hydrophilic) Contact Lenses is indicated for the correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes who exhibit refractive astigmatism of 2.00D or less where the astigmatism does not interfere with visual acuity. Eyecare practitioners may prescribe the lens for either single-use disposable wear, or for frequent/planned replacement wear, with cleaning, disinfection, and scheduled replacement. When prescribed for frequent replacement, the lens may be disinfected using a chemical disinfection system only. The VISCO Soft (Hydrophilic) Contact Lenses help protect against transmission of harmful UV radiation to the cornea and into the eye.
Product codes
LPL, MVN
Device Description
- The VISCO Soft Contact Lens is a spherical lens with UV blocker.
- The VISCO Soft Contact Lens is available in hemispherical shell.
- The lens material is a silicon combination hydrogel. It is a copolymer of - 1-vinyl-2-pyrrolidinone (NVP) and Siloxane macromer. The water content is 47%.
- The VISCO Soft Contact Lens is light blue tinted with "reactive Blue19" for handling visibility purpose.
- A benzotriazole UV absorbing monomer is used to block UV radiation. The transmittance characteristics are less than 5% (1.1%) in the UVB range of 280-315nm and less than 50% (9.4%) in the UVA range of 316-380nm.
- The lens is supplied in a sterile state, packaged in a buffered saline solution.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cornea and into the eye
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Eyecare practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Nonclinical Tests Performed:
- Physiochemical studies were conducted according to ISO 18369 First edition 2006-08-15, Ophthalmic optics - Contact lenses (Ophthalmic). The physical, optical and chemical properties of the lens are within established specifications for the lenses.
- Toxicology studies report shows that the lenses are non-toxic and biocompatibility result is acceptable in ocular environment.
Clinical Studies:
The clinical performance result proves that the safety and effectiveness of the VISCO soft contact lens is non-inferior to the BIOFINITY (comfilcon A) Soft Contact Lens currently marketed by Cooper Vision Inc.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
June 22, 2015
Visco Vision Inc. % Ms. Jennifer Ting Jens Medical Consulting Ltd. 6F No 39, Ln 224, Jixian Rd Luzhou Dist. 247 TW New Taipei City Taiwan R.O.C
Re: K141348
Trade/Device Name: Visco Soft Contact Lens Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (Hydrophilic) Contact Lens Regulatory Class: Class II Product Code: LPL, MVN Dated: Mav 18, 2014 Received: May 22, 2014
Dear Ms. Ting:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing
1
(21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and Part 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"
(21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Kesia Y. Alexander -A
for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K141348
Device Name VISCO Soft Contact Lens
Indications for Use (Describe)
The VISCO Soft (Hydrophilic) Contact Lenses is indicated for the correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes who exhibit refractive astigmatism of 2.00D or less where the astigmatism does not interfere with visual acuity. Eyecare practitioners may prescribe the lens for either single-use disposable wear, or for frequent/planned replacement wear, with cleaning, disinfection, and scheduled replacement. When prescribed for frequent replacement, the lens may be disinfected using a chemical disinfection system only. The VISCO Soft (Hydrophilic) Contact Lenses help protect against transmission of harmful UV radiation to the cornea and into the eye.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
005_510(K) SUMMARY
Preparation Date: May 29, 2015
5.1 Establishment Information:
| Name | Visco Vision Inc. |
|---|---|
| Address | 2F, No. 789, Bo-Ai Street, Chubei City, Hsinchu County, 302 |
| Taiwan, R.O.C. | |
| Phone No. | 886-3-6205516 |
| Fax No. | 886-3-5536268 |
5.2 Owner:
| Company | Visco Vision Inc. |
|---|---|
| Name | Ted TT Huang |
| Address | 2F, No. 789, Bo-Ai Street, Chubei City, Hsinchu County, 302- |
| Taiwan, R.O.C. | |
| Phone No. | 886-3-6205516 |
| Fax No. | 886-3-5536268 |
5.3 US Agent:
| Name | Jessica LeeChen |
|---|---|
| Address | 44855 Lafayette Dr. Novi, MI 48377 USA |
| Phone No | (248)380-6686 |
| jessicaleechen@yahoo.com |
5.4 Contact Person:
| Name | Jennifer TING |
|---|---|
| Phone No | 886-2-82823192 |
| Fax No | 886-2-82867686 |
| e-mail: | jen.medical@msa.hinet.net |
5.5 Device Identification:
| Proprietary Name | VISCO Soft Contact Lens |
|---|---|
| Common Name | Soft (hydrophilic) Contact Lenses |
| Classification Name | Lenses, Soft Contact, Daily Wear (21 CFR 886.5925 |
| Product Code LPL) | |
| Lenses, Soft Contact, Daily Wear (Disposable), | |
| (21 CFR 886.5925, Product Code MVN) | |
| Classification | II |
4
5.6 Legally Marketed Equivalent Device:
| Predicate Device Name | Biofinity (comfilcon A) |
|---|---|
| Manufacturer | CooperVision Inc. |
| 510(k) Number | K052560 |
| Product Code | LPL, MVN |
5.7 Device Description
- The VISCO Soft Contact Lens is a spherical lens with UV blocker. -
- -The VISCO Soft Contact Lens is available in hemispherical shell.
- The lens material is a silicon combination hydrogel. It is a copolymer of - 1-vinyl-2-pyrrolidinone (NVP) and Siloxane macromer. The water content is 47%.
- The VISCO Soft Contact Lens is light blue tinted with "reactive Blue19" for handling visibility purpose.
- -A benzotriazole UV absorbing monomer is used to block UV radiation. The transmittance characteristics are less than 5% (1.1%) in the UVB range of 280-315nm and less than 50% (9.4%) in the UVA range of 316-380nm.
- The lens is supplied in a sterile state, packaged in a buffered saline solution. -
5.8 Indication for Use:
The VISCO Soft (Hydrophilic) Contact Lenses is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes who exhibit refractive astigmatism of 2.00D or less where the astigmatism does not interfere with visual acuity. Eyecare practitioners may prescribe the lens for either single-use disposable wear, or for frequent/planned replacement wear, with cleaning, disinfection, and scheduled replacement. When prescribed for frequent replacement, the lens may be disinfected using a chemical disinfection system only. The VISCO Soft (Hydrophilic) Contact Lenses help protect against transmission of harmful UV radiation to the cornea and into the eye.
5.9 Technological characteristics
The spherical lens design specification:
- Diameter 13.0 mm to 15.0 mm
- Center Thickness 0.08mm @ -3.00D (Varies with Power) ●
- Base Curve 8.0 mm to 9.2 mm ●
- Power -20.00D to +20.00D
5
The physical properties of the lenses are:
- Refractive index: 1.410 (hydrated)
- Light transmittance: > 94%
- Water content: 47% by weight in normal saline
- 150 x 10-11 Oxygen permeability ●
- (cm²/sec)(ml O2/ml.mmHg) measured at 35°C
(intrinsic Dk-Colormetric method)
5.10 Comparison table:
●
The characteristic comparison to predicate device is summarized in the following table.
| Similarities | ||
|---|---|---|
| Item | Device | Predicate (K052560) |
| Product Name | VISCO Soft Contact Lens | BIOFINITY (comfilcon A) |
| Soft Contact Lens | ||
| Manufacturer | VISCO Technology | CooperVision Inc. |
| Intended Use | Myopia, Hyperopia | The same |
| USAN Name | Olifilcon A | comfilcon A |
| Material | Silicone Hydrogel | Silicone Hydrogel |
| Lens Design | Spherical | Spheric, aspheric, toric or |
| multifocal | ||
| Classification | Class II, | The same |
| Type | Group I (low water, nonionic) | The same |
| Water Content | 47 % | 48 % |
| Oxygen Permeability | ||
| (DK, 35°C ) | 150 | |
| (Fatt method) | 128 | |
| (Fatt method) | ||
| Base Curve Range | 8.0~9.2 | 8.0~9.5 |
| Diameter (mm) | 13.0~15.0 | 13.5~15.0 |
| Center Thickness | Varies with design and power | |
| (0.08 mm at -3.00D) | 0.05 mm – 0.50 mm | |
| Powers | -20.00D to +20.00D in 0.25 | |
| steps | The same | |
| Replacement Schedule | Daily wear or Daily | |
| Disposable (Single use) | daily wear | |
| Refractive Index | 1.410 | 1.40 |
| Light Transmittance | 94% | >97% |
6
| Method of
| Manufacture | Cast-Molded | The same |
|---|---|---|
| Surface Treatment | No | No |
| Sterilization | steam | The same |
| Packaging | Blister pack | The same |
| Blue handling tint | Yes, reactive Blue19 | Yes, Phthalocyanine Blue |
| Mechanical Strength | Device | Predicate
(K052560) | Predicate
(K000384) |
|-------------------------|-----------------|----------------------------|------------------------|
| Product Name | Visco | Biofinity
(comfilcon A) | Frequency 55 |
| Tensile strength (Mpa) | $0.55 \pm 0.06$ | $0.50 \pm 0.07$ | 0.66 |
| Modulus (Mpa) | $0.59 \pm 0.05$ | $0.8 \pm 0.1$ | 0.48 |
| Elongation at break (%) | $106 \pm 5$ | $130 \pm 2$ | 179 |
| toughness (J/m³) | $0.26 \pm 0.02$ | | 0.38 |
| Manufacturing method | Cast Mold | Cast Mold | Cast Mold |
5.11 Nonclinical Tests Performed
- 5.11.1 Physiochemical studies were conducted according to ISO 18369 First edition 2006-08-15, Ophthalmic optics - Contact lenses (Ophthalmic). The physical, optical and chemical properties of the lens are within established specifications for the lenses.
- 5.11.2 Toxicology studies report shows that the lenses are non-toxic and biocompatibility result is acceptable in ocular environment.
5.12 Clinical Studies
The clinical performance result proves that the safety and effectiveness of the VISCO soft contact lens is non-inferior to the BIOFINITY (comfilcon A) Soft Contact Lens currently marketed by Cooper Vision Inc.
5.13 Conclusion
Comparison to the predicate device for chemical composition, physical and optical properties, it shows that "VISCO Soft Contact Lens" is as safe, as effective and performs as well as the predicate device.